ACON, NSW’s leading LGBTQ+ health organisation, welcomes the State Government’s announcement of a drug checking trial at music festivals in 2025, marking a significant step forward in harm reduction and public health.

ACON CEO Michael Woodhouse commended NSW Premier Minns and Minister for Health Park for their leadership on this important initiative.

“We congratulate the Premier and Minister Park for prioritising the health and safety of festivalgoers with this evidence-based trial. Public health improvements happen when policy and programs follow the evidence,” Woodhouse said.

The trial will provide festivalgoers with access to detailed information about the substances they may consume, informing decision making and minimising risks.

“More information about the drug supply creates more opportunities to reduce harm. Drug checking is a practical and proven initiative that empowers individuals while improving safety across our communities.”

Drug checking has been shown in other jurisdictions to improve access to support, reduce drug-related harm and save lives. ACON strongly supports harm reduction initiatives that put public health first.

“This trial demonstrates a forward-thinking and practical response to a complex issue. It is one more component in the effort to reduce drug related harm,” Woodhouse said.

ACON looks forward to working closely with the government and other stakeholders to ensure the trial is well implemented and if successful becomes a permanent fixture in NSW’s approach to harm minimisation.

ACON will also continue to work with the government to promote a comprehensive evidence-based responses to reduce drug related harm.

ENDS

David Alexander, ACON Media and Communications

E: dalexander@acon.org.au T: (02) 9206 2044  M: 0428 477 042